146 related articles for article (PubMed ID: 29249122)
1. Vitamin D and melanoma: state of the art and possible therapeutic uses.
Paolino G; Moliterni E; Corsetti P; Didona D; Bottoni U; Calvieri S; Mattozzi C
G Ital Dermatol Venereol; 2019 Feb; 154(1):64-71. PubMed ID: 29249122
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D status and risk for malignant cutaneous melanoma: recent advances.
Ombra MN; Paliogiannis P; Doneddu V; Sini MC; Colombino M; Rozzo C; Stanganelli I; Tanda F; Cossu A; Palmieri G
Eur J Cancer Prev; 2017 Nov; 26(6):532-541. PubMed ID: 28125434
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor immunohistochemistry variability in sun-exposed and non-sun-exposed melanomas.
Paolino G; Panetta C; Cota C; Didona D; Moliterni E; Di Mattia C; De Vita G; Bottoni U; Donati P; Calvieri S
Melanoma Res; 2017 Feb; 27(1):17-23. PubMed ID: 27792059
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features, vitamin D serological levels and prognosis in cutaneous melanoma of shield-sites: an update.
Paolino G; Moliterni E; Didona D; Garelli V; Corsetti P; Lopez T; Richetta AG; Cantisani C; Bottoni U; Calvieri S
Med Oncol; 2015 Jan; 32(1):451. PubMed ID: 25516505
[TBL] [Abstract][Full Text] [Related]
5. Sun exposure before and after a diagnosis of cutaneous malignant melanoma: estimated by developments in serum vitamin D, skin pigmentation and interviews.
Idorn LW; Philipsen PA; Wulf HC
Br J Dermatol; 2011 Jul; 165(1):164-70. PubMed ID: 21457211
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D and melanoma and non-melanoma skin cancer risk and prognosis: a comprehensive review and meta-analysis.
Caini S; Boniol M; Tosti G; Magi S; Medri M; Stanganelli I; Palli D; Assedi M; Marmol VD; Gandini S
Eur J Cancer; 2014 Oct; 50(15):2649-58. PubMed ID: 25087185
[TBL] [Abstract][Full Text] [Related]
7. Prognostic correlation between vitamin D serological levels, Body Mass Index and clinical-pathological features in melanoma patients.
Moliterni E; Paolino G; Veronese N; Bottoni U; Corsetti P; Cardone M; Didona D; Lopez T; Calvieri S
G Ital Dermatol Venereol; 2018 Oct; 153(5):732-733. PubMed ID: 30246955
[No Abstract] [Full Text] [Related]
8. Vitamin D in treated melanoma patients on follow up.
MacKie RM
Br J Dermatol; 2010 Mar; 162(3):697. PubMed ID: 20030636
[No Abstract] [Full Text] [Related]
9. Re: Sun exposure and mortality from melanoma.
Kalish RS
J Natl Cancer Inst; 2005 Aug; 97(15):1158; author reply 1159-62. PubMed ID: 16077076
[No Abstract] [Full Text] [Related]
10. Vitamin D status and skin cancer risk independent of time outdoors: 11-year prospective study in an Australian community.
van der Pols JC; Russell A; Bauer U; Neale RE; Kimlin MG; Green AC
J Invest Dermatol; 2013 Mar; 133(3):637-641. PubMed ID: 23076499
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D and melanoma.
Egan KM
Ann Epidemiol; 2009 Jul; 19(7):455-61. PubMed ID: 19282200
[TBL] [Abstract][Full Text] [Related]
12. Melanoma risk is associated with vitamin D receptor gene polymorphisms.
Zeljic K; Kandolf-Sekulovic L; Supic G; Pejovic J; Novakovic M; Mijuskovic Z; Magic Z
Melanoma Res; 2014 Jun; 24(3):273-9. PubMed ID: 24638155
[TBL] [Abstract][Full Text] [Related]
13. Decreased vitamin D serum levels at melanoma diagnosis are associated with tumor ulceration and high tumor mitotic rate.
Moreno-Arrones OM; Zegeer J; Gerbo M; Manrique-Silva E; Requena C; Traves V; Nagore E
Melanoma Res; 2019 Dec; 29(6):664-667. PubMed ID: 31469708
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial.
De Smedt J; Van Kelst S; Boecxstaens V; Stas M; Bogaerts K; Vanderschueren D; Aura C; Vandenberghe K; Lambrechts D; Wolter P; Bechter O; Nikkels A; Strobbe T; Emri G; Marasigan V; Garmyn M
BMC Cancer; 2017 Aug; 17(1):562. PubMed ID: 28835228
[TBL] [Abstract][Full Text] [Related]
15. Monitoring vitamin D in the patient with melanoma: impact of sun avoidance on vitamin D levels of patients with melanoma at a U.K. tertiary-referral melanoma service.
Lo MCI; Maraka J; Garioch J; John WG; Moncrieff M
Br J Dermatol; 2017 Jul; 177(1):282-283. PubMed ID: 27639181
[No Abstract] [Full Text] [Related]
16. Circulating vitamin D-binding protein and free 25-hydroxyvitamin D concentrations in patients with melanoma: A case-control study.
Navarrete-Dechent C; Del Puerto C; Molgó M; González S; Pérez-Mateluna G; Uribe P; Camargo CA; Borzutzky A
J Am Acad Dermatol; 2017 Sep; 77(3):575-577. PubMed ID: 28807113
[No Abstract] [Full Text] [Related]
17. No evidence for reduced 25-hydroxyvitamin D serum level in melanoma patients.
Reichrath J; Querings K
Cancer Causes Control; 2004 Feb; 15(1):97-8. PubMed ID: 15049326
[No Abstract] [Full Text] [Related]
18. Sun exposure, vitamin D, and risk of Hodgkin and non-Hodgkin lymphoma.
Negri E
Nutr Cancer; 2010; 62(7):878-82. PubMed ID: 20924963
[TBL] [Abstract][Full Text] [Related]
19. The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival.
Orlow I; Shi Y; Kanetsky PA; Thomas NE; Luo L; Corrales-Guerrero S; Cust AE; Sacchetto L; Zanetti R; Rosso S; Armstrong BK; Dwyer T; Venn A; Gallagher RP; Gruber SB; Marrett LD; Anton-Culver H; Busam K; Begg CB; Berwick M;
Pigment Cell Melanoma Res; 2018 Mar; 31(2):287-296. PubMed ID: 28990310
[TBL] [Abstract][Full Text] [Related]
20. High serum vitamin D level correlates with better prognostic indicators in primary melanoma: A pilot study.
Lim A; Shayan R; Varigos G
Australas J Dermatol; 2018 Aug; 59(3):182-187. PubMed ID: 28332194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
